Not Signed In - All Topic Areas
1 - 10 of 35 more >>
News
1 - 5 of 7 more >>
- Novel Pathway Identifies Rapamycin As Tumor Angiogenesis Inhibitor
MedicalNewsToday - Thu, 17 Aug 2006 06:00 EST
- Rapamycin Shown To Inhibit Angiogenesis:New Findings Further Support Drug's Role As Cancer Treatment
MedicalNewsToday - Thu, 17 Aug 2006 05:00 EST
- MacuSight Announces FDA Acceptance Of IND For Novel Ophthalmic Drug Candidate
MedicalNewsToday - Wed, 09 Aug 2006 06:00 EST
- Antibiotic May Protect The Heart New Study Shows
MedicalNewsToday - Sat, 08 Jul 2006 11:00 EST
- New Study Shows Antibiotic May Protect The Heart
ScienceDaily - Wed, 05 Jul 2006 02:00 EST
Clinical Trials
1 - 5 of 21 more >>
- Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis
ClinicalTrials.gov Identifier: NCT00152308 - Recruiting
Coronary Disease
- Rapamycin+Estradiol- vs. Rapamycin-Eluting Stents to Reduce Restenosis (ISAR-PEACE)
ClinicalTrials.gov Identifier: NCT00402636 - Completed
Coronary Heart Disease
- Rapamycin Vs Methotrexate in Diffuse SSc
ClinicalTrials.gov Identifier: NCT00241189 - Active, not recruiting
Systemic Sclerosis
- Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)
ClinicalTrials.gov Identifier: NCT00350454 - Active, not recruiting
Coronary Heart Disease
- Rapamycin With Grapefruit Juice for Advanced Malignancies
ClinicalTrials.gov Identifier: NCT00375245 - Recruiting
Tumors; Neoplasm Metastasis
email this page
print this page
bookmark this page
feedback on this page
